Manchester Intermittent versus Daily Diet App Study (MIDDAS): A pilot randomized controlled trial in patients with type 2 diabetes

S. McDiarmid, M. Harvie, Rhona Johnson, A. Vyas, Azza Aglan, J. Moran, Helen Ruane, A. Hulme et al.

Diabetes, obesity and metabolism, 2021

21 citations

Abstract

To test the feasibility and potential efficacy of remotely supported intermittent low‐energy diets (ILEDs) and continuous low‐energy diets (CLEDs) in people with type 2 diabetes (T2D) and the feasibility of a randomized controlled trial comparing the two approaches.

How strong is the evidence?

Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

• DOI
• PubMed
• Publisher page

Related studies

• Chaos and quantum thermalization Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics, 1994
• The Dalton quantum chemistry program system Wiley Interdisciplinary Reviews. Computational Molecular Science, 2013
• Cord Blood Leptin and Adiponectin as Predictors of Adiposity in Children at 3 Years of Age: A Prospective Cohort Study Pediatrics, 2009
• Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes PloS one, 2010
• Stable adiabatic quantum batteries Physical Review E, 2019
• A novel self-lipid antigen targets human T cells against CD1c(+) leukemias The Journal of experimental medicine, 2014

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free